COF
58
3
C
60
2
MU
36
5
STX
56
4
BF.B
31
3
GIS
28
2
CVS
50
2
VRSN
57
4
SLG
66
2
ADSK
68
2
FOXA
59
4
TEL
66
6
AFL
49
3
DHR
38
3
XYL
45
8
TRV
56
3
VNO
50
-9
SO
57
2
CMCSA
52
4
PRU
62
5
COF
58
3
C
60
2
MU
36
5
STX
56
4
BF.B
31
3
GIS
28
2
CVS
50
2
VRSN
57
4
SLG
66
2
ADSK
68
2
FOXA
59
4
TEL
66
6
AFL
49
3
DHR
38
3
XYL
45
8
TRV
56
3
VNO
50
-9
SO
57
2
CMCSA
52
4
PRU
62
5
Financhill
Back

enVVeno Medical 10K Form

Sell
26

NVNO
enVVeno Medical

Last Price:
3.32
Seasonality Move:
-6.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVNO News And Ratings

See the #1 stock for the next 7 days that we like better than NVNO

NVNO Financial Statistics

Sales & Book Value

Annual Sales: $31.24K
Cash Flow: $-4.29M
Price / Cash Flow: 0
Annual Sales: $2.70
Price / Book: 1.22

Profitability

EPS (TTM): -1.29000
Net Income (TTM): $-21.24M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

enVVeno Medical Earnings Forecast

Key enVVeno Medical Financial Ratios

  • The Gross Profit Margin over the past 3 years for NVNO is 0.00%.
  • The Selling, General & Administrative Expenses for NVNO have been equal to 15,722.18% of Gross Profit Margin.
  • The Interest Expense is -52.61% of Operating Income.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

enVVeno Medical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: NVNO
Website: envveno.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NVNO Technical Analysis vs Fundamental Analysis

Sell
26
enVVeno Medical (NVNO) is a Sell

Is enVVeno Medical a Buy or a Sell?

  • enVVeno Medical stock is rated a Sell
    The current enVVeno Medical [NVNO] share price is $3.30. The Score for NVNO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.